Also for 2019, CMS proposed to provide separate payment for non-opioid pain management drugs that function as a supply when used in a surgical procedure when the procedure is performed in an ASC. HCPCS code C9290, Exparel, is the only code that CMS identified as meeting the proposed criteria right now.
As we expected, CMS did not propose to add any total joint replacement codes to the ASC-payable list for 2019.
Comments on the proposed rule are due on September 24, 2018, so if you read this before then, we urge you to support ASCA’s advocacy efforts by submitting your own comments.
Chief Executive Officer